Corpus Cavernosum from Men with Vasculogenic Impotence Is Partially Resistant to Adenosine Relaxation due to Endothelial A2B Receptor Dysfunction

Although adenosine has been implicated in penile erection in human males, the receptor subtype responsible for adenosine regulation of human corpus cavernosum (HCC) smooth muscle tone is still a matter of debate. Using selective adenosine agonists and antagonists, we aimed at characterizing the adenosine receptors mediating relaxation of precontracted (with 1 μM phenylephrine) HCC strips. HCC specimens were collected from control subjects (organ donors) and from patients with severe vasculogenic erectile dysfunction (ED). In control subjects, adenosine and 5′-N-ethyl-carboxamide adenosine (NECA) fully relaxed HCC. The selective A2A receptor agonist 2-[4-(2-p-carboxy ethyl)phenylamino]-5′-N-ethylcarboxamido adenosine (CGS21680C) produced only a partial relaxation (30-50%) of HCC, which could be further enhanced by simultaneous application of 100 μM NECA. The selective A2B receptor antagonist N-(4-acetylphenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-il)phenoxy] acetamida (MRS1706) (10 nM) attenuated NECA-induced relaxation without affecting CGS21680C action. The A2A receptor antagonist 4-{2-[7-amino-2-(2-furyl)[1,2,4]triazolo-[2,3-a][1,3,5]triazin-5-ylamino]ethyl}phenol (ZM241385) (50 nM) consistently reduced the actions of both agonists. In contrast to CGS21680C, NECA-induced relaxation was attenuated when endothelial production of NO and prostanoids was reduced by 100 μM NG-nitro-l-arginine and 10 μM indomethacin, respectively. HCC strips from patients with vasculogenic ED were partially resistant to NECA but kept relaxation to CGS21680C; the remaining effect was sensitive to blockade of A2A receptors with 50 nM ZM241385. Data suggest that adenosine regulates HCC smooth muscle tone through the activation of two receptor populations, CGS21680C-sensitive (A2A) and -insensitive (A2B) receptors, located on smooth muscle fibers and on endothelial cells, respectively. Endothelial dysfunction may be correlated with a loss of adenosine A2B receptor activity in penile vessels from men with vasculogenic ED.

[1]  I. Thompson,et al.  Erectile dysfunction and subsequent cardiovascular disease. , 2005, JAMA.

[2]  A. Gow,et al.  Oral Session O04: Intracellular signaling in glia and neurons , 2005 .

[3]  J. Huidobro-Toro,et al.  A2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade. , 2005, American journal of physiology. Heart and circulatory physiology.

[4]  P. Correia‐de‐Sá,et al.  Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A2A and extrajunctional inhibitory A1 receptors , 2004, British journal of pharmacology.

[5]  S. Jamal Mustafa,et al.  Relaxation by adenosine and its analogs of potassium-contracted human coronary arteries , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  J. Kostis,et al.  Overview of phosphodiesterase 5 inhibition in erectile dysfunction. , 2003, The American journal of cardiology.

[7]  R. Cunha,et al.  Ecto‐AMP Deaminase Blunts the ATP‐Derived Adenosine A2A Receptor Facilitation of Acetylcholine Release at Rat Motor Nerve Endings , 2003, The Journal of physiology.

[8]  M. Safar,et al.  Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  W. Martin,et al.  Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase , 2002, British journal of pharmacology.

[10]  P. Cuevas,et al.  Regulation of human penile smooth muscle tone byprostanoid receptors , 2002, British journal of pharmacology.

[11]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[12]  K. Andersson Pharmacology of penile erection. , 2001, Pharmacological reviews.

[13]  H. Inoue,et al.  Role of adenosine and P2 receptors in the penile tumescence in anesthetized dogs. , 2001, European journal of pharmacology.

[14]  R. Tabrizchi,et al.  Pharmacology of adenosine receptors in the vasculature. , 2001, Pharmacology & therapeutics.

[15]  C. Müller Adenosine receptor ligands-recent developments part I. Agonists. , 2000 .

[16]  K. Klotz Adenosine receptors and their ligands , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[17]  H. Zimmermann Extracellular metabolism of ATP and other nucleotides , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  M. Mancini,et al.  Functional adenosine receptors in human corpora cavernosa. , 2000, International journal of andrology.

[19]  K. Jacobson,et al.  Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. , 2000, Journal of medicinal chemistry.

[20]  J. Linden,et al.  Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. , 1999, Molecular pharmacology.

[21]  T. Cocks,et al.  Adenosine mediates relaxation of human small resistance‐like coronary arteries via A2B receptors , 1999, British journal of pharmacology.

[22]  N. Gonzalez-Cadavid,et al.  Nitric Oxide and the Cyclic GMP System in the Penis. , 1999, Molecular urology.

[23]  I. Goldstein,et al.  Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. , 1998, The Journal of urology.

[24]  J. Dobson,et al.  Adenosine A2a receptors increase arterial endothelial cell nitric oxide. , 1998, The Journal of surgical research.

[25]  T. Ogura,et al.  Membrane currents underlying the modified electrical activity of guinea‐pig ventricular myocytes exposed to hyperosmotic solution , 1997, The Journal of physiology.

[26]  A. Garcı́a-Sacristán,et al.  Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries. , 1997, Clinical science.

[27]  L. Sobrevia,et al.  Activation of A2‐purinoceptors by adenosine stimulates L‐arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells. , 1997, The Journal of physiology.

[28]  M. Watkins,et al.  Prostanoid production in rabbit corpus cavernosum: I. regulation by oxygen tension. , 1996, The Journal of urology.

[29]  E. Tsai,et al.  Adenosine modulation of neurotransmission in human uterine arteries. , 1996, Molecular human reproduction.

[30]  F. Ledda,et al.  The potent relaxant effect of adenosine in rabbit corpora cavernosa is nitric oxide independent and mediated by A2 receptors. , 1995, Journal of Andrology.

[31]  P. Singh,et al.  The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist , 1995, British journal of pharmacology.

[32]  A. Kosar,et al.  Adenosine: a new agent in the diagnosis of impotence. , 1994, International journal of impotence research.

[33]  E. Tsai,et al.  Adenosine modulation of neurotransmission in penile erection. , 1994, British journal of clinical pharmacology.

[34]  T. Iwamoto,et al.  Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. , 1994, Biochemical and biophysical research communications.

[35]  I. Goldstein,et al.  Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. , 1992, The Journal of urology.

[36]  G. Broderick,et al.  Correlations of purinergic, cholinergic and adrenergic functions in rabbit corporal cavernosal tissue. , 1992, Pharmacology.

[37]  J. Rogers,et al.  Indomethacin-associated sexual dysfunction. , 1989, The Journal of family practice.

[38]  R. Morgan,et al.  Prostacyclin synthesis by the corpora cavernosa of the human penis: evidence for muscarinic control and pathological implications. , 1986, Prostaglandins, leukotrienes, and medicine.

[39]  J. Daly Adenosine receptors: targets for future drugs. , 1982, Journal of medicinal chemistry.